Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (37)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Chatterjee, R.
Right arrow Articles by Morris, I.D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chatterjee, R.
Right arrow Articles by Morris, I.D.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 15, No. 4, 762-766, April 2000
© 2000 European Society of Human Reproduction and Embryology

Testicular and sperm DNA damage after treatment with fludarabine for chronic lymphocytic leukaemia

R. Chatterjee1,4, G.A. Haines1, D.M.D. Perera1, A. Goldstone2 and I.D. Morris3

1 Departments of Obstetrics and Gynaecology and 2 Haematology, University College Hospital, London WC1E 6AU, and 3 Division of Physiology, Pharmacology and Toxicology, School of Biological Sciences, University of Manchester, Oxford Road, Manchester M13 9PT, UK

This study investigated whether chemotherapy using fludarabine (FLU) caused testicular damage and if cytotoxicity could be detected as sperm DNA damage in the single cell Comet assay. A patient with chronic lymphocytic leukaemia requesting preservation of fertility was treated with seven monthly cycles of fludarabine (45.8 mg total dose per cycle). Testicular assessments, serum follicle stimulating hormone (FSH), luteinizing hormone (LH), and testosterone measurements, semen analysis and sperm Comet assays were carried out at presentation (pre-FLU therapy), after 1 and 7 months of FLU treatment, and finally at 11 months after completion of chemotherapy. We found that testicular damage occurred within a month, as indicated by reduced testicular volume, oligozoospermia, elevated FSH and LH, and lower testosterone concentrations. Spermatozoa with a large range of DNA damage were detected in the samples from both the control and treated men. DNA damage in the spermatozoa was marked by 7 months of FLU treatment. The high levels of sperm DNA damage seen during and possibly persisting after treatment suggests that caution should be exercised if the ejaculates from these men are used for in-vitro fertility treatment. Further experiments are needed to assess the biological significance of these DNA changes; it may, however, be prudent at present to be cautious when counselling these patients.

Key words: chemotherapy/Comet assay/DNA damage/fertility/spermatozoa

4 To whom correspondence should be addressed at: Obstetric Hospital, Reproductive Medicine Unit (OH2), Huntley Street, London WC1E 6AU, UK


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum ReprodHome page
A.M. Codrington, B.F. Hales, and B. Robaire
Exposure of male rats to cyclophosphamide alters the chromatin structure and basic proteome in spermatozoa
Hum. Reprod., May 1, 2007; 22(5): 1431 - 1442.
[Abstract] [Full Text] [PDF]


Home page
CA Cancer J ClinHome page
B. Simon, S. J. Lee, A. H. Partridge, and C. D. Runowicz
Preserving Fertility After Cancer
CA Cancer J Clin, July 1, 2005; 55(4): 211 - 228.
[Abstract] [Full Text] [PDF]


Home page
J AndrolHome page
A. M. Codrington, B. F. Hales, and B. Robaire
Spermiogenic Germ Cell Phase-Specific DNA Damage Following Cyclophosphamide Exposure
J Androl, May 1, 2004; 25(3): 354 - 362.
[Abstract] [Full Text] [PDF]


Home page
J AndrolHome page
L. Deane, S. Sharir, K. Jarvi, and A. Zini
High Levels of Sperm DNA Denaturation as the Sole Semen Abnormality in a Patient After Chemotherapy for Testis Cancer
J Androl, January 1, 2004; 25(1): 23 - 24.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
L. Suomalainen, J. K. Hakala, V. Pentikainen, M. Otala, K. Erkkila, M. O. Pentikainen, and L. Dunkel
Sphingosine-1-Phosphate in Inhibition of Male Germ Cell Apoptosis in the Human Testis
J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5572 - 5579.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
L. Migliore, A. Naccarati, A. Zanello, R. Scarpato, L. Bramanti, and M. Mariani
Assessment of sperm DNA integrity in workers exposed to styrene
Hum. Reprod., November 1, 2002; 17(11): 2912 - 2918.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
G. A. Haines, J. H. Hendry, C. P. Daniel, and I. D. Morris
Germ Cell and Dose-Dependent DNA Damage Measured by the Comet Assay in Murine Spermatozoaa after Testicular X-Irradiation
Biol Reprod, September 1, 2002; 67(3): 854 - 861.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
D. Perera, A. Pizzey, A. Campbell, M. Katz, J. Porter, M. Petrou, D.S. Irvine, and R. Chatterjee
Sperm DNA damage in potentially fertile homozygous {beta}-thalassaemia patients with iron overload
Hum. Reprod., July 1, 2002; 17(7): 1820 - 1825.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
I.D. Morris, S. Ilott, L. Dixon, and D.R. Brison
The spectrum of DNA damage in human sperm assessed by single cell gel electrophoresis (Comet assay) and its relationship to fertilization and embryo development
Hum. Reprod., April 1, 2002; 17(4): 990 - 998.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
L. Ramos and A. M. M. Wetzels
Low rates of DNA fragmentation in selected motile human spermatozoa assessed by the TUNEL assay
Hum. Reprod., August 1, 2001; 16(8): 1703 - 1707.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
J. F. V. de la Calle, E. Rachou, M.-T. le Martelot, B. Ducot, L. Multigner, and P. F. Thonneau
Male infertility risk factors in a French military population
Hum. Reprod., March 1, 2001; 16(3): 481 - 486.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.